Technical Analysis for ARNI - Arno Therapeutics

Grade Last Price % Change Price Change
grade D 0.0016 14.29% 0.0002
ARNI closed up 14.29 percent on Thursday, August 22, 2019, on 1 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ARNI trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 14.29%
Stochastic Buy Signal Bullish 14.29%
Bollinger Band Squeeze Range Contraction 14.29%

Older signals for ARNI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Arno Therapeutics, Inc. is an early-stage company focused on developing products for the treatment of cancer and other life threatening diseases. The Company's product development pipeline includes Onapristone, AR-42, and AR-12 and analogs. Onapristone is indicated for endometrial, prostate and breast cancer indications. AR-42 is provided for hematological malignancies and solid tumors indications. AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets. Onapristone is a type 1 anti-progestin hormone blocker that has considerable anti-tumor activity in patients with breast cancer. The Company is engaged in developing and commercializing AR-42, which is an oral cancer therapy in early clinical development. AR-42 is a spectrum deacetylase inhibitor of both histone and non-histone proteins, which has potency and activity in solid tumors and hematological malignancies. AR-12 is an orally available cancer treatment.
Medicine RTT Cancer Clinical Medicine Drugs Diseases Treatment Of Cancer Alcohols Chemotherapy Solid Tumors Breast Cancer Antineoplastic Drugs Cancer Treatment Cancer Therapy Treating Cancer Amines Estranes Hematological Malignancies Tumors Of The Hematopoietic And Lymphoid Tissues
Is ARNI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.12
52 Week Low 0.0005
Average Volume 21,449
200-Day Moving Average 0.023
50-Day Moving Average 0.0023
20-Day Moving Average 0.0015
10-Day Moving Average 0.0015
Average True Range 0.0007
ADX 9.0
+DI 67.3913
-DI 52.1739
Chandelier Exit (Long, 3 ATRs ) 0.0003
Chandelier Exit (Short, 3 ATRs ) 0.0033
Upper Bollinger Band 0.0018
Lower Bollinger Band 0.0012
Percent B (%b) 0.67
BandWidth 40.0
MACD Line -0.0003
MACD Signal Line -0.0002
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0016
Resistance 3 (R3) 0.0016 0.0016 0.0016
Resistance 2 (R2) 0.0016 0.0016 0.0016 0.0016
Resistance 1 (R1) 0.0016 0.0016 0.0016 0.0016 0.0016
Pivot Point 0.0016 0.0016 0.0016 0.0016 0.0016
Support 1 (S1) 0.0016 0.0016 0.0016 0.0016 0.0016
Support 2 (S2) 0.0016 0.0016 0.0016 0.0016
Support 3 (S3) 0.0016 0.0016 0.0016
Support 4 (S4) 0.0016